Seeing Is Believing
Currently out of the existing stock ratings of Michael Okunewitch, 1 are a HOLD (8.33%), 11 are a BUY (91.67%).
Analyst Michael Okunewitch, currently employed at MAXIM GROUP, carries an average stock price target met ratio of 21.43% that have a potential upside of 31.39% achieved within 12 days.
Michael Okunewitch’s has documented 23 price targets and ratings displayed on 7 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on HCWB, HCW Biologics at 28-May-2025.
Analyst best performing recommendations are on ANEB (ANEBULO PHARMACEUTICALS).
The best stock recommendation documented was for ANEB (ANEBULO PHARMACEUTICALS) at 5/15/2025. The price target of $3 was fulfilled within 69 days with a profit of $1.99 (197.03%) receiving and performance score of 28.56.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$15
$9.9 (194.12%)
$10
2 months 14 days ago
(29-Jul-2025)
0/5 (0%)
$11.53 (332.28%)
Buy
$11
$5.9 (115.69%)
$12
2 months 16 days ago
(27-Jul-2025)
0/4 (0%)
$7.67 (230.33%)
Buy
1 years 3 months 23 days ago
(20-Jun-2024)
0/1 (0%)
$26.23 (139.74%)
Buy
$9
$3.9 (76.47%)
2 years 5 months 2 days ago
(11-May-2023)
0/3 (0%)
$7.1 (373.68%)
Buy
2 years 6 months 16 days ago
(27-Mar-2023)
0/1 (0%)
$17.08 (114.48%)
Which stock is Michael Okunewitch is most bullish on?
Which stock is Michael Okunewitch is most reserved on?
What Year was the first public recommendation made by Michael Okunewitch?